Jacobs Levy Equity Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Jacobs Levy Equity Management's OGN Position: Q2 2026 in Review
Jacobs Levy Equity Management sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 58,657 shares — an estimated $351K sold.
Jacobs Levy Equity Management first reported a position in OGN in Q3 2021 and held it in 13 quarters. The position peaked at $23.8M in Q3 2024. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Jacobs Levy Equity Management reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
- Jacobs Levy Equity Management sold 58,657 Organon & Co shares in Q2 2026, an estimated $351K.
- Jacobs Levy Equity Management first reported a position in Organon & Co in Q3 2021 and held it in 13 quarters.
- Jacobs Levy Equity Management's Organon & Co position peaked at $23.8M in Q3 2024.
- 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.